Categories: News

Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference

CAESAREA, Israel, Oct. 15, 2024 /PRNewswire/ — Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee’s Oral Delivery of Biologics Platform at the 14th Annual PODD Conference – Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024.

Presentation Title: “Breakthrough Device for Oral Delivery of Biologics”
Date & Time: October 22, 2024, 2:30 PM2:45 PM
Presenter: Dr. Gil Cohen, PhD, VP R&D

Epitomee’s presentation will cover the following topics:

  • The Epitomee Platform enables oral delivery of significant amounts of large molecules, including proteins and peptides.
  • The platform dramatically boosts bioavailability, offering game-changing alternative to traditional injections.
  • Epitomee’s advanced, needle-free platform precisely transports drugs to the small intestine and across the GI wall, ensuring effective bioavailability.

The PODD Conference, in its 14th year, brings together over 800+ delegates from pharma, biotech, drug delivery, investors and academia. The event fosters collaboration across industries, to develop more effective therapies, improve the patient experience and extend the lifecycle of medicines. PODD features innovative technologies to enhance the delivery of various drug types, including proteins, peptides, oncology therapeutics, small molecules and others. This year’s annual keynote will be delivered by Dr. Robert Langer of MIT.

Join us at PODD 2024 to learn how Epitomee Medical is transforming biologics delivery.

About Epitomee Medical:
Epitomee Medical, co-founded by Shimon Eckhouse, PhD and led by CEO Dan Hashimshony, PhD, is a pioneering health solutions company, committed to advancing innovative therapies. With a focus on safety, efficacy, and improving quality of life, Epitomee leads advancements in weight management and biologic drug delivery. For more information, visit: epitomeemedical.com

Contact details: Safi Landskroner, VP of Business Development: safi@epitomeemedical.com

Photo – https://healthtechnologynet.com/wp-content/uploads/2024/10/PODD_2024.jpg
Logo – https://healthtechnologynet.com/wp-content/uploads/2024/10/Epitomee_Medical_Logo.jpg 

View original content to download multimedia:https://www.prnewswire.com/news-releases/epitomee-medical-to-present-the-epitomee-breakthrough-oral-delivery-platform-at-podd-2024-conference-302276347.html

SOURCE Epitomee Medical

Staff

Recent Posts

Largest Virginia FQHC Leverages eClinicalWorks and Sunoh.ai to Witness Significant Time-Savings and Reduced Physician Burnout

eClinicalWorks and the AI medical scribe assist the 126-provider health center in completing documentation at…

1 hour ago

The New Clinically Integrated Network of Indiana Launches to Improve Access, Quality, and Affordability of Healthcare Statewide

INDIANAPOLIS, Nov. 22, 2024 /PRNewswire/ -- Health centers across the state of Indiana have joined…

1 hour ago

International Genomics Conference (ICG-19) Opens at BGI Group HQ in Shenzhen

SHENZHEN, China, Nov. 22, 2024 /PRNewswire/ -- The 19th Annual Meeting of the International Conference…

1 hour ago

MIT Sloan Professor Steven Eppinger Joins SurgiBox’s Board of Directors

CAMBRIDGE, Mass., Nov. 22, 2024 /PRNewswire/ -- SurgiBox, a pioneer in ultra-portable, inflatable surgical environments…

1 hour ago

Legal Notice Regarding ESHA Data Security Incident

FORT WORTH, Texas, Nov. 22, 2024 /PRNewswire/ -- ESHA, Inc ("ESHA") provide certain revenue cycle…

1 hour ago